The 3D printing technology provides revolutionary roles in the fast evolving field of medical technology. China-based company, Revotek, announced their custom-made 3D bioprinter that can print real blood vessels and other multiple layers of cells. What makes this news truly revolutionary is that no other commercially available 3D bioprinters have done this before.
Yang Keng, Revotek’s chairman, noted that the company’s new 3D bioprinting system includes bio inks, medical imaging cloud platform, a 3D bioprinter, and a post processing system. With this new 3D printing system, it will now be easier to rebuild organs from scratch in the future.
The heart of this new technology is the stem cell culture system called the Biosynsphere biological bricks that are developed to create personalized cells. It contains seed cells as well as bio inks to create layered cell structures with defined physiological functions.
The new 3D printer works by alternately extruding bio inks, thus, it can create 10cm-long blood vessels under two minutes. The bio ink, on the other hand, is kept under special biological and environmental conditions so that the printer does not only make blood vessels but also various types of cells as well. But perhaps the most important component of this new 3D bioprinting system is the medical imaging cloud platform which will be available to all hospitals in China. This makes it easier for doctors and medical researchers to deal with bottleneck problems when it comes to treating different conditions using 3D bioprinted organs.
With this new revolution, 3D printing can pave the way for better medical procedures for patients who require organ transplants.